Abstract:RNA-guided and RNA-targeting type IV-D CRISPR/Cas systems (CRISPR/Cas13d) have recently been identified and employed for efficient and specific RNA knockdown in mammalian and plant cells. Cas13d possesses dual RNase activities and is capable of processing CRISPR arrays and cleaving target RNAs in a protospacer flanking sequence (PFS)-independent manner. These properties make this system a promising tool for multiplex gene expression regulation in microbes. Herein, we aimed to establish a CRISPR/Cas13d-mediated RNA knockdown platform for bacterial chassis. CasRx, Cas13d from Ruminococcus flavefaciens XPD3002, was selected due to its high activity. However, CasRx was found to be highly toxic to both Escherichia coli and Corynebacterium glutamicum, especially when it cooperated with its guide and target RNAs. After employing a low copy number vector, a tightly controlled promoter, and a weakened ribosome binding site, we successfully constructed an inducible expression system for CasRx and applied it for repressing the expression of a green fluorescent protein (GFP) in E. coli. Despite our efforts to optimize inducer usage, guide RNA (gRNA) architecture and combination, and target gene expression level, the highest gene repression efficiency was 30–50% at the protein level and ∼70% at the mRNA level. The moderate RNA knockdown is possibly caused by the collateral cleavage activity toward bystander RNAs, which acts as a mechanism of type IV-D immunity and perturbs microbial metabolism. Further studies on cellular response to CRISPR/Cas13d and improvement in RNA knockdown efficiency are required prior to practical application of this system in microbes.

Efficient and Reversible Cas13d-mediated Knockdown with an All-in-one Lentivirus-Vector

CRISPR/Cas13d-Mediated Microbial RNA Knockdown

A More Efficient RNAi Inducible System for Tight Regulation of Gene Expression in Mammalian Cells and Xenograft Animals.

dCas13-mediated translational repression for accurate gene silencing in mammalian cells

High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects.

Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster Using CRISPR/CasRx

Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme

Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model

A CRISPR/RfxCas13d-mediated strategy for efficient RNA knockdown in mouse embryonic development

Engineered CRISPR RNA improves the RNA cleavage efficiency of hfCas13X

A Method of Constructing Knockin Vector to Achieve Reversible Protein Expression

Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors

Intrinsic RNA Targeting Constrains the Utility of CRISPR-Cas13 Systems

A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference

Shotgun Knockdown of RNA by CRISPR-Cas13d in Fission Yeast.

Abrogation of PRRSV infectivity by CRISPR-Cas13b-mediated viral RNA cleavage in mammalian cells

Targeted gene silencing in the nervous system with CRISPR-Cas13

Establishing a dual knock-out cell line by lentivirus based combined CRISPR/Cas9 and Loxp/Cre system

Low copy CRISPR-Cas13d mitigates collateral RNA cleavage

A High-Throughput Microdroplet-Based Single Cell Transfection Method for Gene Knockout Based on the CRISPR/Cas9 System

Intrinsic targeting of host RNA by Cas13 constrains its utility